257 related articles for article (PubMed ID: 11952037)
1. Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy.
Kaspar M; Archibald C; De BA; Li AW; Yamada M; Chang CH; Kahaly G; Wall JR
Thyroid; 2002 Mar; 12(3):187-91. PubMed ID: 11952037
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
3. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism.
Kubota S; Gunji K; Ackrell BA; Cochran B; Stolarski C; Wengrowicz S; Kennerdell JS; Hiromatsu Y; Wall J
J Clin Endocrinol Metab; 1998 Feb; 83(2):443-7. PubMed ID: 9467555
[TBL] [Abstract][Full Text] [Related]
4. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
[TBL] [Abstract][Full Text] [Related]
5. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
6. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood lymphocyte transformation to G2s in patients with autoimmune thyroid disease with and without ophthalmopathy.
Chang CH; Yamada M; Blanchard ME; Li AW; Wall JR
Autoimmunity; 2002 Aug; 35(5):313-7. PubMed ID: 12515285
[TBL] [Abstract][Full Text] [Related]
8. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy.
Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall J
Thyroid; 1998 Feb; 8(2):175-9. PubMed ID: 9510127
[TBL] [Abstract][Full Text] [Related]
9. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
Mizokami T; Salvi M; Wall JR
J Endocrinol Invest; 2004 Mar; 27(3):221-9. PubMed ID: 15164997
[TBL] [Abstract][Full Text] [Related]
10. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor.
Yamada M; Li AW; West KA; Chang CH; Wall JR
Autoimmunity; 2002 Sep; 35(6):403-13. PubMed ID: 12568121
[TBL] [Abstract][Full Text] [Related]
11. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
13. Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis.
Gopinath B; Ma G; Wall JR
Thyroid; 2007 Nov; 17(11):1123-9. PubMed ID: 17887926
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
Kiljanski JI; Peele K; Stachura I; Pickeral J; Stolarski C; Kennerdell JS; Wall JR
J Endocrinol Invest; 1997 Nov; 20(10):585-91. PubMed ID: 9438915
[TBL] [Abstract][Full Text] [Related]
16. Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens.
Gunji K; Kubota S; Swanson J; Kiljanski J; Bednarczuk T; Wengrowicz S; Salvi M; Wall JR
Thyroid; 1998 Jun; 8(6):553-6. PubMed ID: 9669297
[TBL] [Abstract][Full Text] [Related]
17. Role of eye muscle antibody measurement in diagnosis of thyroid-associated ophthalmopathy: a laboratory update.
Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall JR
Endocr Pract; 1998; 4(3):127-32. PubMed ID: 15251739
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction.
Gopinath B; Adams CL; Musselman R; Tani J; Wall JR
Ocul Immunol Inflamm; 2007; 15(2):81-8. PubMed ID: 17558832
[TBL] [Abstract][Full Text] [Related]
19. New assays for the measurement of serum antibodies reactive with eye muscle membrane antigens confirm their significance in thyroid-associated ophthalmopathy.
Barsouk A; Wengrowicz S; Scalise D; Stolarski C; Nebes V; Sato M; Wall JR
Thyroid; 1995 Jun; 5(3):195-200. PubMed ID: 7580267
[TBL] [Abstract][Full Text] [Related]
20. Thyroid-associated ophthalmopathy in black South African patients with Graves' disease: relationship to antiflavoprotein antibodies.
Joffe B; Gunji K; Panz V; Zouvanis M; Swanson J; Ackrell BA; Wall JR
Thyroid; 1998 Nov; 8(11):1023-7. PubMed ID: 9848717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
